[HTML][HTML] Registered clinical trials investigating ketamine and esketamine for treatment-resistant depression: A systematic review

M Brendle, A Ragnhildstveit, M Slayton… - Journal of …, 2023 - akjournals.com
Abstract Background and Aims Ketamine and esketamine have garnered interest in both
psychiatric research and clinical practice for treatment-resistant depression (TRD). In this …

Registered clinical trials investigating ketamine and esketamine for treatment-resistant depression: A systematic review.

M Brendle, A Ragnhildstveit, M Slayton… - Journal of …, 2022 - psycnet.apa.org
Abstract Background and Aims: Ketamine and esketamine have garnered interest in both
psychiatric research and clinical practice for treatment-resistant depression (TRD). In this …

[PDF][PDF] Registered clinical trials investigating ketamine and esketamine for treatment-resistant depression: A systematic review

S CUNNINGHAM, MH ZIMMERMAN… - Journal of …, 2022 - researchgate.net
ABSTRACT Background and Aims: Ketamine and esketamine have garnered interest in
both psychiatric research and clinical practice for treatment-resistant depression (TRD). In …

[PDF][PDF] Registered clinical trials investigating ketamine and esketamine for treatment-resistant depression: A systematic review

S CUNNINGHAM, MH ZIMMERMAN… - Journal of …, 2022 - reidrobison.com
ABSTRACT Background and Aims: Ketamine and esketamine have garnered interest in
both psychiatric research and clinical practice for treatment-resistant depression (TRD). In …

[PDF][PDF] Registered clinical trials investigating ketamine and esketamine for treatment-resistant depression: A systematic review

S CUNNINGHAM, MH ZIMMERMAN, P SELI… - Journal of Psychedelic …, 2022 - irlg.org
ABSTRACT Background and Aims: Ketamine and esketamine have garnered interest in
both psychiatric research and clinical practice for treatment-resistant depression (TRD). In …